危重症 COVID-19 患者中的肺血栓栓塞症。
Pulmonary thromboembolism in critical ill COVID-19 patients.
机构信息
Division of Diagnostic Imaging, Department of Surgical and Biomedical Sciences, Santa Maria della Misericordia Hospital, University of Perugia, Perugia, Italy.
Department of Anaesthesia and Intensive Care, University Hospital Pisa, Pisa, Italy.
出版信息
Int J Infect Dis. 2020 Jun;95:361-362. doi: 10.1016/j.ijid.2020.04.056. Epub 2020 Apr 24.
Abstract
• COVID-19 in critically ill patients causes death not only from pneumonia but also from multiple organ injuries. • In critically ill COVID-19 patients with pneumonia, pulmonary thromboembolism may be considered. • In critically ill COVID-19 patients, contrast-enhanced computed tomography of the chest is mandatory to assess parenchymal patterns and to diagnose pulmonary thromboembolism.
摘要
• 危重症 COVID-19 患者的死亡原因不仅是肺炎，还有多器官损伤。 • 对于合并肺炎的危重症 COVID-19 患者，可能需要考虑肺血栓栓塞症。 • 对于危重症 COVID-19 患者，必须进行胸部增强 CT 检查以评估实质模式并诊断肺血栓栓塞症。
相似文献
1
Pulmonary thromboembolism in critical ill COVID-19 patients.危重症 COVID-19 患者中的肺血栓栓塞症。
Int J Infect Dis. 2020 Jun;95:361-362. doi: 10.1016/j.ijid.2020.04.056. Epub 2020 Apr 24.
2
COVID-19: opening a new paradigm in thromboprophylaxis for critically ill patients?新冠病毒肺炎：为重症患者的血栓预防开启新范式？
Crit Care. 2020 Jun 11;24(1):332. doi: 10.1186/s13054-020-03052-9.
3
[Six cases of acute pulmonary embolism associated with COVID-19].6例与新型冠状病毒肺炎相关的急性肺栓塞
Rev Med Liege. 2020;75(S1):94-100.
4
Convalescent plasma for COVID-19: the risk of pulmonary embolism should not be underestimated!用于治疗新冠肺炎的康复期血浆：肺栓塞风险不应被低估！
Crit Care. 2020 Aug 28;24(1):531. doi: 10.1186/s13054-020-03236-3.
5
Novel coronavirus pneumonia and acute pulmonary thromboembolism: casualty or causality?新型冠状病毒肺炎与急性肺血栓栓塞症：是致死因素还是因果关系？
Einstein (Sao Paulo). 2020 Jun 3;18:eAI5750. doi: 10.31744/einstein_journal/2020AI5750. eCollection 2020.
6
Pulmonary embolism in a young pregnant woman with COVID-19.一名感染新冠病毒的年轻孕妇发生肺栓塞
Thromb Res. 2020 Jul;191:36-37. doi: 10.1016/j.thromres.2020.04.022. Epub 2020 Apr 20.
7
Pulmonary embolism response teams in the challenging era of venous thromboembolism associated with COVID-19.新冠疫情相关静脉血栓栓塞症这一充满挑战的时代中的肺栓塞应对小组
J Vasc Surg Venous Lymphat Disord. 2020 Sep;8(5):898-899. doi: 10.1016/j.jvsv.2020.04.032. Epub 2020 Jun 1.
8
Thromboembolism and the Pandemic.血栓栓塞与大流行
J Am Coll Cardiol. 2020 Nov 3;76(18):2073-2075. doi: 10.1016/j.jacc.2020.09.543.
9
Optimizing the Risk-Benefit Balance of Thromboprophylaxis in Critically Ill Patients With Coronavirus Disease 2019.优化2019冠状病毒病重症患者血栓预防的风险效益平衡
Crit Care Med. 2020 Oct;48(10):e988-e989. doi: 10.1097/CCM.0000000000004509.
10
Clinical features of critically ill patients with confirmed COVID-19.新型冠状病毒肺炎确诊重症患者的临床特征
J Infect. 2020 Jul;81(1):147-178. doi: 10.1016/j.jinf.2020.03.023. Epub 2020 Apr 28.
引用本文的文献
1
SARS-CoV-2 ORF7a activates the endothelium to release von Willebrand factor that promotes thrombosis.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的开放阅读框7a（ORF7a）激活内皮细胞，使其释放血管性血友病因子，从而促进血栓形成。
Res Pract Thromb Haemost. 2025 Jun 20;9(4):102947. doi: 10.1016/j.rpth.2025.102947. eCollection 2025 May.
2
Immunoglobulins in COVID-19 pneumonia: from the acute phase to the recovery phase.新型冠状病毒肺炎患者的免疫球蛋白：从急性期到恢复期。
Eur J Med Res. 2024 Apr 6;29(1):223. doi: 10.1186/s40001-024-01824-5.
3
Passive antibody therapy in emerging infectious diseases.新发传染病中的被动抗体疗法。
Front Med. 2023 Dec;17(6):1117-1134. doi: 10.1007/s11684-023-1021-y. Epub 2023 Dec 2.
4
Antiphospholipid Antibodies Occurrence in Acute SARS-CoV-2 Infection without Overt Thrombosis.急性新型冠状病毒2型感染中抗磷脂抗体的出现情况：无明显血栓形成
Biomedicines. 2023 Apr 22;11(5):1241. doi: 10.3390/biomedicines11051241.
5
Overexpression of estrogen receptor GPER1 and G1 treatment reduces SARS-CoV-2 infection in BEAS-2B bronchial cells.过表达雌激素受体 GPER1 和 G1 处理可减少 BEAS-2B 支气管细胞中的 SARS-CoV-2 感染。
Mol Cell Endocrinol. 2022 Dec 1;558:111775. doi: 10.1016/j.mce.2022.111775. Epub 2022 Sep 9.
6
High incidence of pulmonary thromboembolism in hospitalized SARS-CoV-2 infected patients despite thrombo-prophylaxis.尽管进行了血栓预防，住院的 SARS-CoV-2 感染患者中仍有很高的肺血栓栓塞发生率。
Heart Lung. 2022 May-Jun;53:77-82. doi: 10.1016/j.hrtlng.2022.02.003. Epub 2022 Feb 8.
7
Venous thromboembolism is linked to severity of disease in COVID-19 patients: A systematic literature review and exploratory meta-analysis.静脉血栓栓塞与 COVID-19 患者的疾病严重程度相关：系统文献回顾和探索性荟萃分析。
Int J Clin Pract. 2021 Dec;75(12):e14910. doi: 10.1111/ijcp.14910. Epub 2021 Sep 28.
8
Pulmonary embolism in COVID-19: Ancillary findings on chest CT angiography.新型冠状病毒肺炎中的肺栓塞：胸部CT血管造影的辅助表现
Lung India. 2021 Mar;38(Supplement):S123-S125. doi: 10.4103/lungindia.lungindia_710_20.
9
The different manifestations of COVID-19 in adults and children: a cohort study in an intensive care unit.成人和儿童 COVID-19 的不同表现：重症监护病房的队列研究。
BMC Infect Dis. 2021 Jan 20;21(1):87. doi: 10.1186/s12879-021-05786-5.
10
Comparison of different anticoagulation strategies for renal replacement therapy in critically ill patients with COVID-19: a cohort study.比较 COVID-19 危重症患者肾替代治疗中不同抗凝策略的队列研究。
BMC Nephrol. 2020 Nov 16;21(1):486. doi: 10.1186/s12882-020-02150-8.
本文引用的文献
1
COVID-19 Complicated by Acute Pulmonary Embolism.新型冠状病毒肺炎合并急性肺栓塞
Radiol Cardiothorac Imaging. 2020 Mar 16;2(2):e200067. doi: 10.1148/ryct.2020200067. eCollection 2020 Apr.
2
Chest CT Features of COVID-19 in Rome, Italy.意大利罗马地区 COVID-19 的胸部 CT 特征。
Radiology. 2020 Aug;296(2):E79-E85. doi: 10.1148/radiol.2020201237. Epub 2020 Apr 3.
3
Acute pulmonary embolism and COVID-19 pneumonia: a random association?急性肺栓塞与新型冠状病毒肺炎：一种随机关联？
Eur Heart J. 2020 May 14;41(19):1858. doi: 10.1093/eurheartj/ehaa254.
4
The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China.抗炎药物在治疗重症新型冠状病毒病 2019（COVID-19）患者中的应用：来自中国临床免疫学家的观点。
Clin Immunol. 2020 May;214:108393. doi: 10.1016/j.clim.2020.108393. Epub 2020 Mar 25.
5
Management strategy of novel coronavirus (COVID-19) pneumonia in the radiology department: a Chinese experience.放射科新型冠状病毒（COVID-19）肺炎的管理策略：中国经验
Diagn Interv Radiol. 2020 May;26(3):200-203. doi: 10.5152/dir.2020.20167.
6
Chest CT manifestations of new coronavirus disease 2019 (COVID-19): a pictorial review.新型冠状病毒病 2019（COVID-19）的胸部 CT 表现：影像学综述。
Eur Radiol. 2020 Aug;30(8):4381-4389. doi: 10.1007/s00330-020-06801-0. Epub 2020 Mar 19.
7
Modified IMPROVE VTE Risk Score and Elevated D-Dimer Identify a High Venous Thromboembolism Risk in Acutely Ill Medical Population for Extended Thromboprophylaxis.改良的IMPROVE VTE风险评分与升高的D-二聚体可识别急性病患者群体中高静脉血栓栓塞风险，以进行延长的血栓预防。
TH Open. 2020 Mar 13;4(1):e59-e65. doi: 10.1055/s-0040-1705137. eCollection 2020 Jan.
8
Comorbidities and multi-organ injuries in the treatment of COVID-19.新型冠状病毒肺炎治疗中的合并症与多器官损伤
Lancet. 2020 Mar 21;395(10228):e52. doi: 10.1016/S0140-6736(20)30558-4. Epub 2020 Mar 11.
9
Performance of Radiologists in Differentiating COVID-19 from Non-COVID-19 Viral Pneumonia at Chest CT.放射科医生在胸部 CT 鉴别 COVID-19 与非 COVID-19 病毒性肺炎中的表现。
Radiology. 2020 Aug;296(2):E46-E54. doi: 10.1148/radiol.2020200823. Epub 2020 Mar 10.
10
Prognostic factors for VTE and bleeding in hospitalized medical patients: a systematic review and meta-analysis.住院内科患者静脉血栓栓塞症和出血的预后因素：系统评价和荟萃分析。
Blood. 2020 May 14;135(20):1788-1810. doi: 10.1182/blood.2019003603.
Zotero 插件